Scripps MD Anderson Cancer Center

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

Journal of Clinical Oncology · 2021 · 1.7K citations · Full text

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares et al. · The Lancet Oncology · 2019 · 1.7K citations · Full text

AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP

James B. Bussel, David J. Kuter, James N. George et al. · New England Journal of Medicine · 2006 · 526 citations · Full text

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

Eric Van Cutsem, Margaret A. Tempero, Darren Sigal et al. · Journal of Clinical Oncology · 2020 · 404 citations · Full text

Epithelioid Inflammatory Myofibroblastic Sarcoma

Adrián Mariño‐Enríquez, Wei‐Lien Wang, Angshumoy Roy et al. · The American Journal of Surgical Pathology · 2010 · 373 citations

Conventional Imt, Rare Imts, Medicine +11